Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7387 p161-162
11 February 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

News feature

No Smoking Day: what pharmacists can do to help smokers kick the habit

With No Smoking Day less than a month away, Tom Moberly (on the staff of The Journal) looks at how pharmacists can prepare for the day and help smokers in the long run

Related websites
No Smoking links


No Smoking DayLast year 1.6 million smokers quit smoking on No Smoking Day and more than a million others used the day to find out about the help available for when they do decide to stop. “This year we expect to break all records and help two million smokers to stop smoking on No Smoking Day,” Sarah Watson, campaign officer for the charity No Smoking Day, says. “Pharmacists are a key element in providing these smokers with support.”

Pharmacists’ role

Pharmacists should support smokers in any way that they think is appropriate, Miriam Armstrong, chief executive of PharmacyHealthLink, says. “Whether it is to refer the smoker to their local NHS stop smoking service or to provide them with nicotine replacement therapy over the counter, they are ideally placed to provide support.

“Tobacco smoking still remains the single greatest cause of preventable illness and premature death in the UK, with more than 100,000 people a year dying from its effects. And currently a third of smokers attempt to stop each year with 70 per cent saying that they would like to stop,” she says. “No Smoking Day is a great opportunity for pharmacists to help smokers focus on their habit.”

No Smoking Day poster

Smoking: latest statistics

In 2003 the average male smoker in the UK smoked 15 cigarettes a day compared with the average female smoker who smoked 13, according to latest official figures published by the Office for National Statistics in January.

Twenty-six per cent of the adult population smoked in 2003, with more men smoking than women — 28 per cent compared with 24 per cent, its report “Focus on health” shows. The biggest groups of smokers, were men aged 20 to 34 years (38 per cent) and women between 20 and 24 years of age (34 per cent).

There was a continued decline in older smokers with just 14 per cent of women and 16 per cent of men over 60 years smoking. But older smokers aged between 50 and 59 years smoked the most, with men getting through 18 cigarettes a day and women getting through 15.

The report also reveals from a separate survey that at least 26 per cent of girls aged 15 years, and 16 per cent of boys the same age smoked regularly in 2004.

Web resources

A number of useful resources related to smoking cessation and No Smoking Day are available on the internet:

No Smoking Day The No Smoking Day website provides information about No Smoking Day 2006 (8 March), the history of the day and its successes, facts about smoking and the benefits of quitting, free-of-charge leaflets to download and information sheets, as well as an online catalogue of materials that can be used for stop smoking events
www.nosmokingday.org.uk

PharmacyHealthLink PharmacyHealthLink has published guidelines on providing NRT to patients and the template for the supply of both NRT and bupropion under patient group direction can be downloaded from the charity’s website
www.pharmacyhealthlink.org.uk

PJ Online PJ Online features a page devoted to information, links and articles about smoking and No Smoking Day

Award-winning pharmacy smoking cessation scheme

A community pharmacy-based smoking cessation scheme received one of the NHS Alliance Acorn Awards, it was announced last week.

Ashton, Leigh and Wigan Primary Care Trust’s scheme was named runner-up in the clinical engagement category.

Over 120 community pharmacists in the PCT have been trained to provide nicotine replacement therapy and the scheme has achieved a 62 per cent four-week quit rate among the 3,200 patients have used the service in the last year.

The NHS Alliance Acorn Awards celebrate success and innovation at the frontline of primary care and the NHS. The winners and runners-up were presented with their awards by the Prince of Wales last week.

This year’s theme is “Serious about stopping … you can do it”. The campaign image uses a question mark (right) made of ash and cigarette butts to remind smokers of the everyday reasons why they want to stop smoking, Ms Watson explains. “It asks smokers if they are serious about stopping and then lets them know that they can do it with the help and support that is available on No Smoking Day and all year round. The best thing pharmacists can do to prepare for No Smoking Day this year is, she says, to access the campaign’s website at: www.nosmokingday.org.uk

The site features resources that can be downloaded free of charge, leaflets in a variety of languages, information sheets and smoker diaries, as well as an online catalogue of materials that pharmacists can purchase to help them set up events to help smokers who are serious about stopping. The last order date for the materials is 28 February 2006.

Rethinking quitting

It may be, however, that pharmacists can play a much bigger part in helping smokers quit than received wisdom has previously suggested, since recent research has found that smokers’ quits attempts are much more impulsive than has been thought. A national survey published online in the BMJ last month (27 January), showed that almost half of attempts to stop were made without prior planning, and that the unplanned attempts succeeded for longer.

Nearly two thirds (65.4 per cent) of unplanned attempts lasted at least six months compared with 42.3 per cent of planned attempts to stop smoking made between six months and five years before the survey.

This may mean we need a serious rethink in terms of understanding how smokers quit, Robert West, of the Cancer Research UK Health Behaviour Unit at University College London and one of the authors of the study, argues.

“We used to think that people would set a date, plan and then try to quit, but quitting without planning is the norm — people are much more responsive to the immediate triggers than we’d previously thought. But that’s not necessarily a bad thing from a pharmacist’s point of view, since it means that pharmacists can help smokers by just offering advice and information about new treatments, without necessarily entering into an in-depth debate about smoking.”

If the pharmacist comes across as knowledgeable and professional, smokers will be attracted to that and willing to listen, he adds. “So, in that situation, the best way that pharmacists can help smokers is by being ready to ‘sell’ the best ways of quitting and that means the NHS stop smoking services and nicotine products.

“If a smoker says ‘I’ve tried this or that nicotine product before and it didn’t work for me’, the pharmacist can offer new flavours or formulations,” he adds. And if someone comes in to buy a cough medicine, the pharmacist can politely ask whether he or she smokes and has tried any of the products available to help smokers quit. “Pharmacists really need to be prepared to sell the concept of stopping and what can be done, as well as being enthusiastic about the help on offer,” he says.

Recent developments

Advances in the licensing of NRT products are also expanding the box of tools pharmacists can offer smokers. At the end of 2005 the Medicines and Healthcare products Regulatory Agency agreed to extend NRT licences to pregnant women, those aged 12–17 years and those suffering from heart disease. And in September 2005 the MHRA approved a new indication for two NRT products — Nicorette gum and inhalators — which can be used by smokers to ‘cut-down’ on their smoking before attempting to stop completely.

“Reducing to stop” has been found to be helpful in the short term, Ms Armstrong explains. “The rationale is that using NRT boosts nicotine levels and makes it easier for the smoker to smoke fewer cigarettes, therefore inhaling fewer toxins. Reducing their reliance on cigarettes for nicotine intake appears to help many smokers to stop smoking completely.”

However, unfounded safety concerns still prevent many of those it could help quit from asking for information about it, Terry Maguire, PharmacyHealthLinks’s vice chairman, says. “Sadly about half of smokers still remain convinced that NRT is dangerous to use and are unwilling to try it so pharmacists have a major role in informing the public that NRT is relatively safe.”

Professor West adds: “The key misconceptions people have about NRT are that nicotine causes cancer — which it doesn’t — and that nicotine products are as addictive as cigarettes, which they aren’t.

“A knowledgeable pharmacist should be able to explain that and help smokers understand that nicotine products release nicotine much more slowly than cigarettes and so are far less addictive.”

Legislation

Smokers planning to quit may also be helped by plans ro reduce the number of places where they are legally allowed to smoke.

On 26 March, the ban on smoking in enclosed public places comes into force in Scotland and the Welsh Assembly Government has said it plans to ban smoking in enclosed public places in Wales.

On 14 February there will be a free vote in Parliament on how far the ban on smoking in public places in England, as outlined in the Health Bill, should extend. Members of Parliament will be able to vote on three options of where the ban should extend to: licensed premises but not membership clubs, licensed premises and membership clubs or non-food-serving pubs and membership clubs.

The Government has also added a clause to the Health Bill which will — following a consultation on raising the age of buying tobacco products — allow ministers to take swift action to raise the age from 16 to 18 years of age.

This latter measure, however, is unlikely to reduce smoking levels, Ms Watson argues. “There is no real evidence that increasing the age at which people can buy cigarettes will affect young people starting to smoke,” she says.

“Almost all smokers start before the age of 16 and the majority of young smokers get their cigarettes from those who are old enough to buy them, or from parents, supplies or sources other than shops.”

People start smoking because it is an expression of freedom and being grown up, she says. “Raising the age reinforces this perception and while it might appear to be a strong counter tobacco policy, the real impact is unlikely to have any tangible health gain. The Government needs to focus on the real and proven ways of reducing tobacco use, such as smoke-free public places.”

Guidance

An imminent policy change that is likely to affect pharmacists involved in helping smokers quit is the National Institute for Health and Clinical Excellence’s consultation on “brief interventions and referral for smoking cessation in primary care and other settings”.

This ongoing consultation — designed for those working in PCTs, primary care, pharmacies and dental practices — will focus on pregnant smokers and disadvantaged groups in particular.

The provisional guidance states that “health professionals, such as pharmacists should, where practicable, recommend smokers to use the NHS stop smoking service”.

It also recommends that smoking cessation advice and support should be made available to all smokers in community, primary and secondary care settings and that pharmacists with suitable training should offer a prescription of NRT to smokers in lieu of a referral to stop smoking services where appropriate. The deadline for comments on the document is February 21.

When the full guidance is published at the end of March, NICE will produce implementation advice, slide sets and costing and audit tools to support implementation — these tools will, NICE says, be available on its website by the end of April.

Future advances

Progress continues to be made in the development of nicotine vaccines and a drug designed to block nicotine’s action.

Last year, in two double-blind placebo-controlled studies of varenicline (Champix; Pfizer), a selective nicotinic acetylcholine receptor partial agonist, 44 per cent of varenicline-treated patients had stopped smoking by the end of the 12-week treatment period, compared with 30 per cent of patients in each study treated with bupropion and 18 per cent of those taking placebo (PJ, 10 December, p716).

Further results of studies involving a vaccine to treat nicotine addiction being developed by Cytos Biotechnology and Nabi Biopharmaceuticals (CYT002-NicQb) were announced last week. Researchers have now identified a dose that will induce sufficiently high levels of antibodies for the vaccine to be effective in most individuals. Last year, research showed that 42 per cent of patients given the vaccine were still not smoking after a year, compared with 21 per cent of those given placebo (P=0.012).

When such products come to market they may be able to provide that little bit more help that those who are ready to give up smoking need to quit for good. In the meantime, pharmacists can offer advice and information about treatments and be enthusiastic about selling the concept of quitting and how pharmacists themselves can help smokers who are serious about giving up.

Back to Top


©The Pharmaceutical Journal